de Knijff P, van den Maagdenberg A M, Frants R R, Havekes L M
TNO Institute of Prevention and Health Research, Gaubius Laboratory, Leiden, The Netherlands.
Hum Mutat. 1994;4(3):178-94. doi: 10.1002/humu.1380040303.
Apolipoprotein E (apoE) is one of the major protein constituents of chylomicron and very-low-density lipoprotein (VLDL) remnants and plays a central role as a ligand in the receptor-mediated uptake of these particles by the liver. Including the most common variant, apoE3, 30 apoE variants have been characterized. At present, 14 apoE variants have been found to be associated with familial dysbetalipoproteinemia, a genetic lipid disorder characterized by elevated plasma cholesterol and triglyceride levels and an increased risk for atherosclerosis. Seven apoE variants were found to be associated with other forms of hyperlipoproteinemia. This report presents an overview of all currently known apoE variants and their effects on lipoprotein metabolism.
载脂蛋白E(apoE)是乳糜微粒和极低密度脂蛋白(VLDL)残粒的主要蛋白质成分之一,在肝脏通过受体介导摄取这些颗粒的过程中作为配体发挥核心作用。包括最常见的变体apoE3在内,已鉴定出30种apoE变体。目前,已发现14种apoE变体与家族性异常β脂蛋白血症相关,这是一种遗传性脂质紊乱,其特征为血浆胆固醇和甘油三酯水平升高以及动脉粥样硬化风险增加。发现7种apoE变体与其他形式的高脂蛋白血症相关。本报告概述了所有目前已知的apoE变体及其对脂蛋白代谢的影响。